Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04799379Completed

Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery

Role: collaborator

NCT03419676Phase 3Completed

Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy

Role: collaborator

NCT04625582Not ApplicableUnknown

Educational Intervention for the Development of Professionals Skills in Family Medicine and Community Nursing Residents

Role: collaborator

NCT01157013Not ApplicableCompleted

Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma

Role: collaborator

All 4 trials loaded